iShares Genomics Immunology & Healthcare ETF (IDNA) Stock
NYSE · IDNA
39.83
Fundamentals
Market cap
$203.44M
Price / Earnings ratio
0.0x
Price / Sales ratio
N/A
Price / Book ratio
N/A
Return on assets
N/A
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
N/A
Dividend yield
0.7%
Debt / Equity ratio
N/A
Latest news
About iShares Genomics Immunology & Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering. The funds provides access to companies at the forefront of genomics and immunology innovation and aims to provide exposure to global stocks along the full value chain of genomics, immunotherapy and healthcare industries.
Fundamentals
Valuation
Market cap$203.44M
Price-to-sales ratioN/A
Price-to-book valueN/A
Price-earnings ratio0.00
Return on EquityN/A
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per ShareN/A
Income Statement
Average volume131,257
EBITDAN/A
1 year high (52w)$41.49
1 year low (52w)$22.33
Dividend
Ex dividend dateN/A
Dividend amountN/A
Dividend yield0.70%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



